NEW YORK (GenomeWeb News) — Genedata today said that Chugai Pharmaceuticals is using its Screener software to analyze high-throughput screening data.
 
Under the agreement, Genedata said its Tokyo-based staff has helped Chugai to integrate its AssayAnalyzer and Condoseo modules to review screening data and to evaluate compounds.
 
Genedata said Chugai has been using the software to help it develop drugs for cancer and for joint and bone diseases.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.